Replies to post #90825 on Cytodyn Inc (CYDY)

[bluefish1]

Side effects of tocilizumab may include the following.

The most common side effects are:

a cough or sore throat, blocked or runny nose
headaches or dizziness
mouth ulcers
high blood pressure
hypercholesterolaemia (increased cholesterol in the blood)
allergic reactions - this can include aching muscles, feeling out of breath, having a tight chest, wheezing, and a high temperature
weight gain or swollen ankles
skin rashes, infections or itching
stomach irritation or abdominal pain.

No thanks. I'll take leronlimab over any of those symptoms.

[Blue Man]

Here the research for Tocilizumab:
"In conclusion, both intravenous and subcutaneous tocilizumab administration might be capable of reducing the risk of invasive mechanical ventilation or death in patients with severe COVID-19 pneumonia. Although these results are encouraging, they should be confirmed in ongoing randomised studies." https://www.thelancet.com/journals/lanrhe/article/PIIS2665-9913(20)30173-9/fulltext

[BioInvestor4]

Source?

[Venture_Cap]

Sounds about right...IL6 blocking is the “fad” Mab right now. Leronlimab will get their approval end of July and outshine tocilizumab.

That being said buy the dips....